Physician profile
Christopher E Lee
NPI 1649391616
$528.41
in general payments reported to CMS, 2019-2025
8 companies · $63.83 in 2025
The $63.83 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.68 · 2022: $35.60 · 2023: $206 · 2024: $126 · 2025: $63.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248 · Honoraria: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.11 |
| Honoraria | $148.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $148.02 | 2023 | Kinevo 900 |
| Stryker Corporation | $115.28 | 2019-2024 | Scopis Ent |
| Intersect Ent, INC. | $81.54 | 2019 | |
| Glaxosmithkline, LLC. | $58.08 | 2023 | |
| Acclarent, INC | $35.60 | 2022 | |
| Davol INC. | $35.53 | 2025 | Arista |
| Ethicon US, LLC | $28.30 | 2025 | Harmonic |
| Hill Dermaceuticals, INC. | $26.06 | 2024 | Tolak |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.